Pascal Deschatelets Net Worth & Insider Trades

Pascal Deschatelets - Chief Scientific Officer, Apellis Pharmaceuticals, Inc

As of September 11, 2023

What is Pascal Deschatelets's Net Worth?

The current estimated net worth of Apellis Pharmaceuticals, Inc's Chief Scientific Officer, Pascal Deschatelets, is estimated to be about $77.03M . Pascal Deschatelets owns about 1,059,813 units of Apellis Pharmaceuticals, Inc common stock. In the last 5 years at Apellis Pharmaceuticals, Inc, Pascal Deschatelets has sold an estimated value of $19.37M worth.

What is Pascal Deschatelets's Past Insider Trading?

Pascal Deschatelets's largest purchase order was 234,411 units , worth over $501.64K on February 14, 2020. Pascal Deschatelets's largest sale order was 107,473 units , worth over $4.5M on February 14, 2020. In total, Pascal Deschatelets has made about 42 transactions over 5 years of their time at Apellis Pharmaceuticals, Inc. Pascal Deschatelets usually trades in February, with the busiest year in 2023. The most recent transaction was a sale order of 12,000 units , worth over $514.44K on September 11, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Pascal Deschatelets

Date Range: All Time
Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What was Pascal Deschatelets's Salary in 2020?

As Chief Scientific Officer of Apellis Pharmaceuticals, Inc, Pascal Deschatelets has a total base salary of $423,500 . Pascal Deschatelets received compensation valued at about $2,918,082 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of a bonus of $239,062 , stock awards of $415,594 , option awards of $1,828,125 , and other compensation of $11,801 .

What is Pascal Deschatelets's' Mailing Address?

  • Mailing address is 6400 Westwind Way Suite A Crestwood KY 40014 KY

Apellis Pharmaceuticals, Inc Executive Compensation

Stock Awards
Option Awards
Other Compensation
Cedric Francois, M.D., Ph.D. 2020 $618,769 $429,687 $1,523,844 $6,703,125 - $9,275,425
Cedric Francois, M.D., Ph.D. 2019 $560,019 $427,893 - $3,279,270 - $4,267,182
Cedric Francois, M.D., Ph.D. 2018 $550,000 $381,562 - $3,127,600 $15,378 $4,074,540
Timothy Sullivan 2020 $430,269 $244,688 $518,129 $2,279,063 $13,000 $3,485,149
Timothy Sullivan 2019 $386,423 $214,730 - $1,108,650 $9,500 $1,719,303
Timothy Sullivan 2018 $380,000 $190,000 - $279,250 $10,502 $859,752
Pascal Deschatelets, Ph.D. 2020 $423,500 $239,062 $415,594 $1,828,125 $11,801 $2,918,082
Pascal Deschatelets, Ph.D. 2019 $404,077 $252,608 - $1,108,650 $55,893 $1,821,228
Pascal Deschatelets, Ph.D. 2018 $400,000 $225,000 - $1,228,700 $8,657 $1,862,357
Nur Nicholson 2020 $138,462 $150,068 - $2,648,750 $84,874 $3,022,154
Adam Townsend 2020 $430,038 $217,500 $415,594 $1,828,125 $9,750 $2,901,007
No matching records found


What are Apellis Pharmaceuticals, Inc's Past Insider Trades?

Apellis Pharmaceuticals, Inc's most recent insider trade came on September 19, 2023 by Alec MacHiels who sold 1,250 units worth $56.25K . In the last 6 years, insiders at Apellis Pharmaceuticals, Inc have sold an estimated value of $95.91M and bought an estimated value of $101.14M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Federico Grossi, Chief Medical Officer,  Alec MacHiels, Director,  and Cedric Francois, Chief Executive Officer .

Apellis Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found